Skip to content

NCBIO News

Recent News

Medical Device Forum discusses current FDA regulatory environment 

May 31, 2022

NCBIO members got an overview of the Food and Drug Administration’s regulatory environment for medical devices both during the pandemic and now at the NCBIO Medical Device Forum held May 11 at the NC Biotechnology Center.

Read More
NCBIO President Laura Gunter and Sam Taylor's wife, Nancy Reed, at the opening of Wake Tech’s Lilly Science and Technology Center

Lead gifts from Alexandria Real Estate, Biogen, Hatteras push Taylor scholarship fund past $200,000

April 8, 2022

The Samuel M. Taylor Memorial Scholarship Fund created by NCBIO at the North Carolina Community Colleges Foundation Inc. has exceeded $200,000 in gifts and pledges with leadership gifts coming from Alexandria Real Estate Equities, Biogen and Hatteras Venture Partners.

Read More

NCBIO forum explores moving technology through funding phases

March 21, 2022

A high quality board of directors and valuable outside partnerships are two advantages that biotech startups would do well to cultivate, according to the expert panelists assembled for the NCBIO Emerging Company and Technology Forum held Wednesday, March 16, at the NC Biotechnology Center.

Read More
Drew Duncan (Biogen), Erica Paine (Chiesi USA), Sheila Mikhail (AskBio) with Nicole Thompson (BD) participating remotely

NCBIO Roadmap to Diversity event offers guidance for member DEI initiatives

March 18, 2022

NCBIO members gathered at the NC Biotechnology Center Wednesday, March 9, to seek inspiration and guidance in pursuing their companies’ diversity, equity and inclusion goals. Some key takeaways from the discussions included the need to weave DEI into everything the company does; it can’t stand alone.

Read More
Scott Ewing, Lilly

BMF presenters share lessons learned commissioning facilities during pandemic

February 25, 2022

At the NCBIO Biomanufacturers Forum held online Feb. 23, representatives from FUJIFILM Diosynth Biotechnologies, Lilly and Project Farma shared what they had learned about commissioning new facilities and equipment during the during the COVID-19 pandemic.

Read More

Life Science Caucus tours NC Reseach Campus in Kannapolis

February 24, 2022

Members of the NC Life Science Caucus toured the NC Research Campus in Kannapolis on Wednesday, Feb. 23, along with local leader and representatives of industry, such as Eli Lilly and Company, which is setting up shop in nearby Concord.

Read More
Rep. Deborah Ross answers questions from NCBIO members

Rep. Ross discusses immigration, IP, workforce and more with NCBIO members

February 16, 2022

Immigration reform, protection of intellectual property, the threat of antimicrobial resistance, workforce training and more were topics covered by Rep. Deborah Ross at an NCBIO legislative round table held Monday, Feb. 14, at the NC Biotechnology Center.

Read More

New report outlines best practices in bioscience economic development

January 20, 2022

BIO and CSBA released a new report on bioscience economic development best practices, “Driving the Bioscience Economy Forward During the COVID-19 Pandemic: Best Practices in State and Regional Economic Development Initiatives.” The report serves as a leading analysis of legislative and regulatory initiatives at the state and regional level for economic development in the bioscience ecosystem.

Read More

Sen. Tillis joins NCBIO members for Q&A

January 14, 2022

Sen. Thom Tillis addressed manufacturing capacity, China, intellectual property protections, workforce development and more with NCBIO members during a legislative forum held online Friday, Jan. 14. He emphasized that he and his staff were eager to hear the concerns, issues and ideas of North Carolina’s life sciences industry.

Read More

NCBIO forum explores ways to improve recruitment and experience for patients in clinical trials

January 4, 2022

Patients and research organizations came together at the NCBIO Clinical Trials Forum to talk about ways to make recruiting and retaining patients easier for clinical trials. The forum was held Wednesday, Dec. 8 at the NC Biotechnology Center.

Read More